Two Women Win Nobel Chemistry Prize for Pioneering CRISPR Gene Editing
Emmanuelle Charpentier and Jennifer A. Doudna receive the Nobel Prize in Chemistry for developing the revolutionary CRISPR-Cas9 genetic scissors. Their simple but powerful technology transforms medical research, even as the award leaves out other key contributors.
Emmanuelle Charpentier and Jennifer A. Doudna win the Nobel Prize in Chemistry for their development of CRISPR, a revolutionary method for genome editing. The Nobel Committee honors the scientists for their 2012 experiment that demonstrates how to cut DNA at specific locations using a specialized protein and a guide molecule. This "genetic scissors" technology transforms laboratory research and enters human clinical trials to cure diseases like blindness and sickle-cell disease.
The award marks the first time a Nobel Prize in any category is shared exclusively by two women. However, the duo's collaboration ends shortly after their breakthrough due to differences over commercializing the technology, with each founder starting separate biotech companies. Despite their shared history, the two researchers now pursue distinct business ventures in Europe and the United States.
The Nobel Committee's decision to leave the third available slot unfilled sparks controversy in the scientific community. Notable figures left out include Virginijus Šikšnys, a Lithuanian biochemist who makes similar discoveries, and Feng Zhang of MIT, who successfully adapts the technology for human cells and wins key patent disputes. Meanwhile, Doudna actively warns the public about the ethical dangers of CRISPR following the controversial 2018 case of a Chinese scientist who creates gene-edited human embryos.